2017 - 2018年德黑兰伊玛目侯赛因医院中性粒细胞减少热患者经验性抗真菌治疗的评价

Fahimeh Hadavand, Simin Dokht Shoaei, H. Noroozi
{"title":"2017 - 2018年德黑兰伊玛目侯赛因医院中性粒细胞减少热患者经验性抗真菌治疗的评价","authors":"Fahimeh Hadavand, Simin Dokht Shoaei, H. Noroozi","doi":"10.5812/jamm-122775","DOIUrl":null,"url":null,"abstract":"Background: Invasive fungal infections are among the most important causes of death in patients with neutropenic fever. Early detection of the cause of neutropenia and appropriate treatment, including experimental antifungal therapy, plays a key role in reducing mortality and cutting financial costs for the individual and society. Methods: In this retrospective study, the records of 33 patients with fever and neutropenia who received antifungal drugs (including Amphotericin B, Voriconazole, Caspofungin, and Fluconazole) were evaluated. Neutropenia was defined as episodes of fever (axillary temperature > 38.2°C or oral temperature > 37.7°C) and neutrophil count < 500 /μL persistent for five days despite antibacterial therapy without an infectious etiology. For statistical analysis, SPSS software version 21 was used. Results: In this study, out of 33 neutropenic patients receiving antifungal therapy, a fungal agent was defined in 19 patients (59%). Mucor species was the most common cause of fungal infections, followed by aspergillus and candida. Liposomal Amphotericin B and Caspofungin were the most common antifungal agents used for treating patients with neutropenic fever. Antifungal therapy in neutropenic patients resulted in 50% recovery and 50% mortality. Statistical analysis showed that neutropenic patients did not have a significant difference in response to treatments based on age groups and gender. Conclusions: The study highlights the importance of experimental therapy in neutropenic patients based on clinical criteria and risk factors, and with a diagnostic approach, rather than general treatment.","PeriodicalId":15058,"journal":{"name":"Journal of Archives in Military Medicine","volume":"96 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of Empirical Antifungal Treatments in Patients with Neutropenic Fever in Imam Hossein Hospital, Tehran, 2017 - 2018\",\"authors\":\"Fahimeh Hadavand, Simin Dokht Shoaei, H. Noroozi\",\"doi\":\"10.5812/jamm-122775\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Invasive fungal infections are among the most important causes of death in patients with neutropenic fever. Early detection of the cause of neutropenia and appropriate treatment, including experimental antifungal therapy, plays a key role in reducing mortality and cutting financial costs for the individual and society. Methods: In this retrospective study, the records of 33 patients with fever and neutropenia who received antifungal drugs (including Amphotericin B, Voriconazole, Caspofungin, and Fluconazole) were evaluated. Neutropenia was defined as episodes of fever (axillary temperature > 38.2°C or oral temperature > 37.7°C) and neutrophil count < 500 /μL persistent for five days despite antibacterial therapy without an infectious etiology. For statistical analysis, SPSS software version 21 was used. Results: In this study, out of 33 neutropenic patients receiving antifungal therapy, a fungal agent was defined in 19 patients (59%). Mucor species was the most common cause of fungal infections, followed by aspergillus and candida. Liposomal Amphotericin B and Caspofungin were the most common antifungal agents used for treating patients with neutropenic fever. Antifungal therapy in neutropenic patients resulted in 50% recovery and 50% mortality. Statistical analysis showed that neutropenic patients did not have a significant difference in response to treatments based on age groups and gender. Conclusions: The study highlights the importance of experimental therapy in neutropenic patients based on clinical criteria and risk factors, and with a diagnostic approach, rather than general treatment.\",\"PeriodicalId\":15058,\"journal\":{\"name\":\"Journal of Archives in Military Medicine\",\"volume\":\"96 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Archives in Military Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5812/jamm-122775\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Archives in Military Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/jamm-122775","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:侵袭性真菌感染是中性粒细胞减少热患者死亡的最重要原因之一。早期发现中性粒细胞减少的原因并进行适当的治疗,包括实验性抗真菌治疗,在降低死亡率和减少个人和社会的经济成本方面发挥着关键作用。方法:回顾性分析33例发热伴中性粒细胞减少患者使用抗真菌药物(两性霉素B、伏立康唑、卡泊芬净、氟康唑)治疗的临床资料。中性粒细胞减少的定义是:尽管进行了抗菌治疗,但仍有发热发作(腋窝温度> 38.2°C或口腔温度> 37.7°C),中性粒细胞计数< 500 /μL持续5天,无感染病因。采用SPSS软件21版进行统计分析。结果:在这项研究中,在33名接受抗真菌治疗的中性粒细胞减少患者中,19名患者(59%)被确定使用真菌药物。毛霉是真菌感染最常见的原因,其次是曲霉和念珠菌。脂质体两性霉素B和卡泊芬净是治疗中性粒细胞减少热患者最常用的抗真菌药物。对中性粒细胞减少患者进行抗真菌治疗,恢复率为50%,死亡率为50%。统计分析显示,中性粒细胞减少症患者对治疗的反应在年龄和性别上没有显著差异。结论:该研究强调了基于临床标准和危险因素的实验性治疗对中性粒细胞减少患者的重要性,并采用诊断方法,而不是一般治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluation of Empirical Antifungal Treatments in Patients with Neutropenic Fever in Imam Hossein Hospital, Tehran, 2017 - 2018
Background: Invasive fungal infections are among the most important causes of death in patients with neutropenic fever. Early detection of the cause of neutropenia and appropriate treatment, including experimental antifungal therapy, plays a key role in reducing mortality and cutting financial costs for the individual and society. Methods: In this retrospective study, the records of 33 patients with fever and neutropenia who received antifungal drugs (including Amphotericin B, Voriconazole, Caspofungin, and Fluconazole) were evaluated. Neutropenia was defined as episodes of fever (axillary temperature > 38.2°C or oral temperature > 37.7°C) and neutrophil count < 500 /μL persistent for five days despite antibacterial therapy without an infectious etiology. For statistical analysis, SPSS software version 21 was used. Results: In this study, out of 33 neutropenic patients receiving antifungal therapy, a fungal agent was defined in 19 patients (59%). Mucor species was the most common cause of fungal infections, followed by aspergillus and candida. Liposomal Amphotericin B and Caspofungin were the most common antifungal agents used for treating patients with neutropenic fever. Antifungal therapy in neutropenic patients resulted in 50% recovery and 50% mortality. Statistical analysis showed that neutropenic patients did not have a significant difference in response to treatments based on age groups and gender. Conclusions: The study highlights the importance of experimental therapy in neutropenic patients based on clinical criteria and risk factors, and with a diagnostic approach, rather than general treatment.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信